Evaluation of the effect of Livergol in reducing peripheral neuropathies induced by cisplati
Not Applicable
Recruiting
- Conditions
- Cancer.Malignant (primary) neoplasm, unspecifiedC80.1
- Registration Number
- IRCT20200825048515N29
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age over 18 years
Newly diagnosed cancer and undergoing chemotherapy with cisplatin
Having symptoms of peripheral neuropathy after starting chemotherapy
Consent to participate in this study
Exclusion Criteria
Having multiple myeloma
Having previous neurological disorders
Having diseases that give rise to peripheral neuropathy (such as diabetes)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chemotherapy induced peripheral neuropathy score. Timepoint: Before and after the intervention. Method of measurement: Chemotherapy Induced Peripheral Neuropathy Assessment Tool (CIPNAT).
- Secondary Outcome Measures
Name Time Method